Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA).
Sleep Med
; 119: 222-228, 2024 Jul.
Article
em En
| MEDLINE
| ID: mdl-38704869
ABSTRACT
Though it is widely prescribed for improving sleep of children with autism and other neurogenetic disorders, there is a need for practical guidance to clinicians on the use of melatonin for managing insomnia in this population. Because data were either lacking or inconclusive, a task force was established by the International Pediatric Sleep Association (IPSA) to examine the literature based on clinical trials from 2012 onwards. A summary of evidence pertaining to melatonin's utility and potential side effects, practice-related caveats, and insights for use are published herewith.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Distúrbios do Início e da Manutenção do Sono
/
Melatonina
Limite:
Child
/
Humans
Idioma:
En
Revista:
Sleep Med
Ano de publicação:
2024
Tipo de documento:
Article